These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25997043)

  • 1. A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.
    Zhang PW; Chen FX; Li D; Ling WH; Guo HH
    Medicine (Baltimore); 2015 May; 94(20):e758. PubMed ID: 25997043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial.
    Sangsefidi ZS; Hosseinzadeh M; Ranjbar AM; Akhondi-Meybodi M; Fallahzadeh H; Mozaffari-Khosravi H
    Nutr J; 2019 Jul; 18(1):39. PubMed ID: 31324181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
    Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
    Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F; Rashidkhani B; Hekmatdoost A
    Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
    Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
    Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
    Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.
    Li D; Zhang Y; Liu Y; Sun R; Xia M
    J Nutr; 2015 Apr; 145(4):742-8. PubMed ID: 25833778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
    Zamani N; Shams M; Nimrouzi M; Zarshenas MM; Abolhasani Foroughi A; Fallahzadeh Abarghooei E; Fattahi MR
    Complement Ther Med; 2018 Dec; 41():118-123. PubMed ID: 30477827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
    Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
    Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M
    Dig Liver Dis; 2015 Mar; 47(3):226-32. PubMed ID: 25577300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers.
    Climax J; Newsome PN; Hamza M; Weissbach M; Coughlan D; Sattar N; McGuire DK; Bhatt DL
    J Am Heart Assoc; 2020 Aug; 9(16):e016334. PubMed ID: 32779505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
    Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
    Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial.
    Darand M; Darabi Z; Yari Z; Hedayati M; Shahrbaf MA; Khoncheh A; Hosseini-Ahangar B; Alavian SM; Hekmatdoost A
    Phytother Res; 2019 Sep; 33(9):2369-2377. PubMed ID: 31293021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
    Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
    Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.
    Mahmoudi L; Asadi S; Al-Mousavi Z; Niknam R
    Clin Nutr; 2021 May; 40(5):2999-3005. PubMed ID: 33341312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial.
    Panahi Y; Kianpour P; Mohtashami R; Atkin SL; Butler AE; Jafari R; Badeli R; Sahebkar A
    Phytother Res; 2018 Jul; 32(7):1382-1387. PubMed ID: 29520889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.